Kazmira Launches New Medical Cannabis Education Platform for Patients and Providers
- Kazmira Therapeutics launched 1Cannabis, an online education platform focused on medical cannabis, particularly cannabidiol (CBD), aimed at both patients and healthcare providers.
- The platform offers separate courses for patients and clinicians, covering basic CBD knowledge for patients and in-depth topics like the endocannabinoid system, safety, drug interactions, and clinical protocols for providers.
- The initiative addresses the knowledge gap among healthcare providers regarding cannabinoid therapies to enable better-informed patient conversations and safer, evidence-based care.
- The launch coincides with new CMS incentives for CBD medical products, highlighting the urgency of provider education; Kazmira also plans telemedicine services and advanced courses in the near future.
Colorado-based Kazmira Therapeutics has launched 1Cannabis, a new online education platform built to give both patients and healthcare providers a clearer understanding of medical cannabis, with an early focus on cannabidiol (CBD).
The platform includes separate programs for patients and clinicians, with Kazmira saying the goal is to close a longstanding knowledge gap around cannabinoid-based care. According to the company, one course is aimed at patients and provides a basic overview of CBD, while two others are tailored for providers and cover topics such as the endocannabinoid system, safety, drug interactions, clinical protocols and patient-specific considerations.
Kazmira says the initiative is meant to help providers have more informed conversations with patients as interest in cannabinoid therapies continues to grow. The company’s co-founder and co-CEO, Pulak Sharma, said patient demand is already well established, but the clinical infrastructure needed to support regulated cannabinoid care has lagged behind. He said physicians have lacked a credible place to receive evidence-based training on prescription cannabinoid options.
Medical advisor Dr. Rachit Marwaha also stressed the need for better provider education, pointing to a recent report in JAMA that found just 5% of patients using cannabis for health reasons had it documented in their electronic medical record. He said that gap makes it harder for providers to identify possible drug interactions and oversee treatment safely.
The launch comes just weeks after the Centers for Medicare & Medicaid Services rolled out a pilot incentive tied to certain CBD medical products, a development Kazmira says makes clinician education even more urgent. The company says telemedicine access through its Cope Now platform is expected to begin in May, while its more advanced CBD201 provider course remains in development.